Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/29676
Title: | SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL | Authors: | Mease, Philip J. Kavanaugh, Arthur Reimold, Andreas Tahir, Hasan Rech, Juergen Hall, Stephen GEUSENS, Piet Pellet, Pascale Delicha, Eumorphia Maria Pricop, Luminita Mpofu, Shephard |
Issue Date: | 2019 | Publisher: | BMJ PUBLISHING GROUP | Source: | ANNALS OF THE RHEUMATIC DISEASES, 78, p. 917-917 (Art N° FRI0451) | Notes: | [Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA. [Mease, Philip J.] Univ Washington, Seattle, WA 98195 USA. [Kavanaugh, Arthur] Univ Calif San Diego, Sch Med, La Jolla, CA USA. [Reimold, Andreas] Dallas VA Med Ctr, Dallas, TX USA. [Reimold, Andreas] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA. [Tahir, Hasan] Barts Hlth NHS Trust, London, England. [Rech, Juergen] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Erlangen, Germany. [Hall, Stephen] Monash Univ, Melbourne, Vic, Australia. [Geusens, Piet] Univ Hasselt, Hasselt, Belgium. [Geusens, Piet] Maastricht Univ Hosp, Maastricht, Netherlands. [Pellet, Pascale; Delicha, Eumorphia Maria; Mpofu, Shephard] Novartis Pharma AG, Basel, Switzerland. [Pricop, Luminita] Novartis Pharmaceut, E Hanover, NJ USA. | Keywords: | Rheumatology | Document URI: | http://hdl.handle.net/1942/29676 | ISSN: | 0003-4967 | e-ISSN: | 1468-2060 | DOI: | 10.1136/annrheumdis-2019-eular.2768 | ISI #: | 000472207102496 | Category: | M | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
mease 1.pdf Restricted Access | Published version | 50.18 kB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
1
checked on Apr 30, 2024
Page view(s)
62
checked on Sep 7, 2022
Download(s)
54
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.